This site is intended for healthcare professionals only
LoginRegister
Reckitt names Ravi B as Director Corporate Communications and Corporate Affairs ( South Asia, MENARP and Africa)Reckitt names Ravi Bhatnagar as Director Corporate Communications and Corporate Affairs (South Asia,...
Suspected spurious drugs worth Rs 5.21 lakh seized in TelanganaSuspected spurious drugs worth Rs 5.21 lakh seized in Hyderabad
Zydus gets USFDA EIR for Ankleshwar API facilityZydus Lifesciences venture capital arm to acquire stake in Agenus for USD 16 million
AstraZeneca collaborates with CSPC Pharma focused on AI-enabled researchAstraZeneca Calquence based regimens approved in EU for previously untreated chronic lymphocytic...
Bristol Myers Squibb, BioNTech ink pactBristol Myers Squibb, BioNTech ink pact to co-develop, co-commercialize investigational bispecific...
Panacea Biotec announces listing of EmulsiPan adjuvant in CEPI Adjuvant LibraryPanacea Biotec announces listing of EmulsiPan adjuvant in CEPI Adjuvant Library
SEC Approves Serums Salk Polio Vaccine for Commercial Use, Recommends Phase I Trial for 21-valent Pneumococcal VaccineSEC Approves Serum's Salk Polio Vaccine for Commercial Use, Recommends Phase I Trial for 21-valent...
Morepen Labs names Vivan Prashar as functional head, (Operations-API)Morepen Labs names Vivan Prashar as functional head, (Operations-API)
NPPA sets retail prices for 41 drugs, including 29 Fixed-Dose Combinations containing Empagliflozin or SitagliptinNPPA sets retail prices for 41 drugs, including 29 Fixed-Dose Combinations containing Empagliflozin...
Roche to proceed with Phase III development of Prasinezumab in early-stage Parkinsons diseaseRoche Evrysdi tablet gets European Commission approval for Spinal Muscular Atrophy
Novartis concludes acquisition of Regulus TherapeuticsZydus Lifesciences to acquire India, Sri Lanka rights for Agenus cancer immunotherapy BOT/BAL
Takeda Adcertris combo approved by European Commission for newly diagnosed Stage IIb/III/IV Hodgkin LymphomaTakeda Adcertris combo approved by European Commission for newly diagnosed Stage IIb/III/IV Hodgkin...
X